ADGRF5 and Insulin resistance: Gema Frühbeck et al.'s study showed that [7] plasma FNDC4 was reduced in morbidly obese patients, and their visceral adipose tissue (AT) showed high expression of FNDC4 and its receptor GPR116, which is not related to the degree of insulin resistance.